title: Staphylococcal bacteraemia: the hospital or the home? A review of Staphylococcus aureus bacteraemia at Concord Hospital in 1993.
abstract: OBJECTIVE
  To examine the risk factors for, and the complications and mortality of, Staphylococcus aureus bacteraemia.
  
  
  METHODS
  A retrospective case review of patients with S. aureus bacteraemia in 1993 diagnosed at the Concord Repatriation General Hospital, Sydney.
  
  
  RESULTS
  Of 104 cases reviewed, 32 were due to methicillin resistant S. aureus (MRSA), 73 were due to methicillin sensitive S. aureus (MSSA) and one was a dual infection. Twenty-eight of the bacteraemias were community-acquired, including one case of MRSA, and 76 were hospital-acquired; 38% had an implanted prosthetic device or graft. The average age (68 years), incidence of underlying diseases and hospitalisation in the past month (26%) did not differ between MRSA and MSSA groups. MRSA was more likely in patients with recent broad-spectrum antibiotic use (53% vs 0, p < .01). Vascular access was the commonest source of sepsis (61%) but in community-acquired cases the source was unknown in 50%. Use of central line access was more predictive of MRSA infection (75% vs 49%, p = .018). In hospital-acquired infection, MRSA sepsis occurred later in the course of the admission (26 days vs eight days, p < .01). Directly attributable mortality was highest in MRSA and community-acquired MSSA infection (9% and 11%) compared with hospital-acquired MSSA infection (1%).
  
  
  CONCLUSIONS
  Nosocomial S. aureus bacteraemia, particularly MRSA, is a major source of preventable morbidity, which could be addressed by improved infection control of MRSA, antibiotic use and attention to central line catheter use.
authors.affiliation: Concord Hospital, Sydney, NSW.
authors.forename: G M
authors.initials: GM
authors.lastname: O'Kane
authors.forename: T
authors.initials: T
authors.lastname: Gottlieb
authors.forename: R
authors.initials: R
authors.lastname: Bradbury
mesh_terms: D000368:Aged; D016470:Bacteremia / Q000150:complications / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D017714:Community-Acquired Infections / Q000150:complications / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D003428:Cross Infection / Q000150:complications / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D016106:Methicillin Resistance; D009517:New South Wales; D012189:Retrospective Studies; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000150:complications / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects